Reference | 1: Ebai CB, Kimbi HK, Sumbele IUN, Yunga JE, Lehman LG. Efficacy and safety of praziquantel against Schistosoma haematobium in the Ikata-Likoko area of southwest Cameroon. Trop Med Health. 2017 Dec 18;45:30. doi: 10.1186/s41182-017-0071-8. eCollection 2017. PubMed PMID: 29270076; PubMed Central PMCID: PMC5733948.<br />
2: Bader C, Jesudoss Chelladurai J, Starling DE, Jones DE, Brewer MT. Efficacy of injectable praziquantel for elimination of trematode metacercariae in bluegills (Lepomis macrochirus) and quantification of parasite death by propidium iodide staining. Parasitol Res. 2017 Dec 20. doi: 10.1007/s00436-017-5703-8. [Epub ahead of print] PubMed PMID: 29264719.<br />
3: Stecher CW, Madsen H, Wilson S, Sacko M, Wejse C, Keita AD, Landouré A, Traoré MS, Kallestrup P, Petersen E, Vennervald B. Organomegaly in Mali before and after praziquantel treatment. A possible association with Schistosoma haematobium. Heliyon. 2017 Nov 14;3(11):e00440. doi: 10.1016/j.heliyon.2017.e00440. eCollection 2017 Nov. PubMed PMID: 29264407; PubMed Central PMCID: PMC5727379.<br />
4: Chan JD, Cupit PM, Gunaratne GS, McCorvy JD, Yang Y, Stoltz K, Webb TR, Dosa PI, Roth BL, Abagyan R, Cunningham C, Marchant JS. The anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligand. Nat Commun. 2017 Dec 5;8(1):1910. doi: 10.1038/s41467-017-02084-0. PubMed PMID: 29208933; PubMed Central PMCID: PMC5716991.<br />
5: Midzi N, Mduluza T, Mudenge B, Foldager L, Leutscher PDC. Decrease in Seminal HIV-1 RNA Load After Praziquantel Treatment of Urogenital Schistosomiasis Coinfection in HIV-Positive Men-An Observational Study. Open Forum Infect Dis. 2017 Sep 15;4(4):ofx199. doi: 10.1093/ofid/ofx199. eCollection 2017 Fall. PubMed PMID: 29181419; PubMed Central PMCID: PMC5695621.<br />
6: Stecher CW, Fofana HKM, Madsen H, Wilson S, Keita AD, Landouré A, Traoré MS, Vennervald BJ, Reimert CM, Sacko M. Inflammation dynamics after praziquantel treatment of Schistosoma haematobium reflected by urinary eosinophil cationic protein. Trans R Soc Trop Med Hyg. 2017 Jul 1;111(7):316-324. doi: 10.1093/trstmh/trx057. PubMed PMID: 29165707.<br />
7: Sayasone S, Keiser J, Meister I, Vonghachack Y, Xayavong S, Senggnam K, Phongluxa K, Hattendorf J, Odermatt P. Efficacy and safety of tribendimidine versus praziquantel against Opisthorchis viverrini in Laos: an open-label, randomised, non-inferiority, phase 2 trial. Lancet Infect Dis. 2017 Nov 16. pii: S1473-3099(17)30624-2. doi: 10.1016/S1473-3099(17)30624-2. [Epub ahead of print] PubMed PMID: 29153938.<br />
8: Sripa B. Tribendimidine: an alternative to praziquantel to treat human liver fluke infection? Lancet Infect Dis. 2017 Nov 16. pii: S1473-3099(17)30675-8. doi: 10.1016/S1473-3099(17)30675-8. [Epub ahead of print] PubMed PMID: 29153937.<br />
9: Whitehouse-Tedd KM, Smith L, Budd JA, Lloyd CG. Suspected adverse reactions to oral administration of a praziquantel-pyrantel combination in captive cheetahs (Acinonyx jubatus). J Am Vet Med Assoc. 2017 Nov 15;251(10):1188-1195. doi: 10.2460/javma.251.10.1188. PubMed PMID: 29099259.<br />
10: Munisi DZ, Buza J, Mpolya EA, Angelo T, Kinung/'hi SM. The Efficacy of Single-Dose versus Double-Dose Praziquantel Treatments on Schistosoma mansoni Infections: Its Implication on Undernutrition and Anaemia among Primary Schoolchildren in Two On-Shore Communities, Northwestern Tanzania. Biomed Res Int. 2017;2017:7035025. doi: 10.1155/2017/7035025. Epub 2017 Sep 28. PubMed PMID: 29094048; PubMed Central PMCID: PMC5637830.
|